Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update

Go back to Seres Therapeutics Reports Second Quarter Financial Results and Provides Progress Update
(NASDAQ: MCRB) Delayed: 6.51 -0.1 (1.51%)
Previous Close $6.61    52 Week High $44.51 
Open $6.68    52 Week Low $8.05 
Day High $7.05    P/E N/A 
Day Low $6.31    EPS $0.00 
Volume 35,308